Contrast-enhanced ultrasonography for characterization of canine focal liver lesions

Veterinary Radiology and Ultrasound

Volumn 51, Issue 1, 2010, Pages 79-85

  Nakamura, Kensuke ^a   Takagi, Satoshi ^a   Sasaki, Noboru ^a   Bandula Kumara, Wickramasekara Rajapakshage ^a   Murakami, Masahiro ^a   Ohta, Hiroshi ^a   Yamasaki, Masahiro ^a   Takiguchi, Mitsuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Contrast; Dog; Liver; Sonazoid ; Tumor; Ultrasonography

Indexed keywords

CONTRAST MEDIUM; FERRIC ION; IRON; NYCOMED; OXIDE;

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BILE DUCT CARCINOMA; CLASSIFICATION; DOG; DOG DISEASE; ECHOGRAPHY; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DOG DISEASES; DOGS; FERRIC COMPOUNDS; HEMANGIOSARCOMA; IRON; LIVER NEOPLASMS; OXIDES; ULTRASONOGRAPHY;

CANIS FAMILIARIS;

EID: 73649119237     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2009.01627.x     Document Type: Article

References (39)

1. Lamb CR. Abdominal ultrasonography in small animals: examination of the liver, spleen and pancreas. J Small Anim Pract 1990 31 : 5 14.
2. Cuccovillo A, Lamb CR. Cellular features of sonographic target lesions of the liver and spleen in 21 dogs and a cat. Vet Radiol Ultrasound 2002 43 : 275 278.
3. Shinmura R, Matsui O, Kadoya M, et al. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2008 18 : 1918 1924.
4. Clifford CA, Pretorius ES, Weisse C, et al. Magnetic resonance imaging of focal splenic and hepatic lesions in the dog. J Vet Intern Med 2004 18 : 330 338.
5. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 2001 11 (Suppl 3) : E27 E34.
6. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007 33 : 318 325.
7. Blomley MJK, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999 25 : 1341 1352.
8. Harvey CJ, Blomley MJ, Eckersley RJ, et al. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A - early experience. Radiology 2000 216 : 903 908.
9. Rabenandrasana HA, Furukawa A, Furuichi K, Yamasaki M, Takahashi M, Murata K. Comparison between tissue harmonic imaging and liver-specific late-phase contrast-enhanced pulse-inversion imaging in the detection of hepatocellular carcinoma and liver metastasis. Radiat Med 2004 22 : 90 97.
10. Heckemann RA, Cosgrove DO, Blomley MJ, Eckersley RJ, Harvey CJ, Mine Y. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience. Radiology 2000 216 : 592 596.
11. von Herbay A, Vogt C, Häussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 2002 179 : 1273 1279. (Pubitemid 35204386)
12. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004 232 : 799 809.
13. Nicolau C, Brú C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004 29 : 348 359.
14. Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. Am J Roentgenol 2006 186 : 158 167.
15. von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004 23 : 1557 1568. (Pubitemid 39586861)
16. Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 2008 48 : 848 857.
17. Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Ishihara M, Fujimaki M. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull 2003 26 : 1272 1277.
18. Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Fujimaki M. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, Sonazoid, in rabbit liver. Biol Pharm Bull 2005 28 : 972 977.
19. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007 42 : 643 651.
20. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008 5 : 61 69.
21. Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008 75 (Suppl 1) : 42 47.
22. Inoue T, Kudo M, Hatanaka K, et al. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with Sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 2008 75 (Suppl 1) : 48 54.
23. Ziegler LE, O'Brien RT, Waller KR, Zagzebski JA. Quantitative contrast harmonic ultrasound imaging of normal canine liver. Vet Radiol Ultrasound 2003 44 : 451 454.
24. O'Brien RT, Iani M, Matheson J, Delaney F, Young K. Contrast harmonic ultrasound of spontaneous liver nodules in 32 dogs. Vet Radiol Ultrasound 2004 45 : 547 553.
25. Nyman HT, Kristensen AT, Kjelgaard-Hansen M, McEvoy FJ. Contrast-enhanced ultrasonography in normal canine liver. Evaluation of imaging and safety parameters. Vet Radiol Ultrasound 2005 46 : 243 250.
26. Kutara K, Asano K, Kito A, et al. Contrast harmonic imaging of canine hepatic tumors. J Vet Med Sci 2006 68 : 433 448.
27. O'Brien RT. Improved detection of metastatic hepatic hemangiosarcoma nodules with contrast ultrasound in three dogs. Vet Radiol Ultrasound 2007 48 : 146 148.
28. Ohlerth S, Ruefli E, Poirier V, Roos M, Kaser-Hotz B. Contrast harmonic imaging of the normal canine spleen. Vet Radiol Ultrasound 2007 48 : 451 456.
29. Waller KR, O'Brien RT, Zagzebski JA. Quantitative contrast ultrasound analysis of renal perfusion in normal dogs. Vet Radiol Ultrasound 2007 48 : 373 377.
30. Rossi F, Leone VF, Vignoli M, Laddaga E, Terragni R. Use of contrast-enhanced ultrasound for characterization of focal splenic lesions. Vet Radiol Ultrasound 2008 49 : 154 164.
31. Kanemoto H, Ohno K, Nakashima K, Takahashi M, Fujino Y, Tsujimoto H. Vascular and Kupffer imaging of canine liver and spleen using the new contrast agent Sonazoid. J Vet Med Sci 2008 70 : 1265 1268.
32. Nakamura K, Sasaki N, Yoshikawa M, et al. Quantitative contrast-enhanced ultrasonography of canine spleen. Vet Radiol Ultrasound 2009 50 : 104 108.
33. Kanemoto H, Ohno K, Nakashima K, et al. Characterization of canine focal liver lesions with contrast-enhanced ultrasound using a novel contrast agent - Sonazoid. Vet Radiol Ultrasound 2009 50 : 188 194.
34. Ivancić M, Long F, Seiler GS. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs. J Am Vet Med Assoc 2009 234 : 88 94.
35. Iijima H, Sasaki S, Moriyasu F, et al. Dynamic US contrast study of the liver: vascular and delayed parenchymal phase. Hepatol Res 2007 37 : 27 34.
36. Liu K, He X, Lei XZ, et al. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003 9 : 1946 1949.
37. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996 24 : 807 812.
38. Inoue T, Kudo M, Maenishi O, et al. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. Am J Roentgenol 2009 192 : 698 705.
39. Fife WD, Samii VF, Drost WT, Mattoon JS, Hoshaw-Woodard S. Comparison between malignant and nonmalignant splenic masses in dogs using contrast-enhanced computed tomography. Vet Radiol Ultrasound 2004 45 : 289 297.